INNOVADERM CRO IS NOW INDERO.

In-Person Breakfast Event at the AAD – Spotlight on Hidradenitis Suppurativa

Indero

Indero

Team of Experts

Innovaderm was in New Orleans for the 2023 edition of the AAD congress and hosted its 4th Breakfast Event: Spotlight on Hidradenitis Suppurativa (HS).

Listen to our world-renowned dermatology key opinion leaders’ presentations to learn about HS and the latest research findings:

  • Dr. Amit Garg, MD​ – Challenges of Current Scales & Development of Novel Strategies
  • Dr. Alexa B. Kimball, MD, MPH – 2023 HS Therapeutic Update
  • Dr. James Krueger, MD, PhD – Promising Molecular Targets for Treatment of HS
SHARE THIS POST

Subscribe to our Podcast.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte près de 30 ans d’expérience dans l’industrie pharmaceutique et CRO, s’étant distingué par son leadership exceptionnel, sa vision stratégique et son innovation. L’expertise de Jeff couvre des opérations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matière de création de valeur, de gestion des partenaires et d’opérations CRO ont toujours contribué au succès dans ses fonctions précédentes. Sous la direction de Jeff, Indero continue d’étendre ses capacités, faisant progresser les connaissances médicales et les nouvelles thérapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≤3 days, and lowers costs, helping teams make informed go/no-go decisions faster.